If you need more lookups,
subscriptions start at $34 USD/month.
Philip Davey Location
Hoddesdon, GB
Philip Davey Work
2025 -now General Manager UK and Ireland and Mid Size Markets (MSM) North @
2022 -2025 Country Manager (VP), UK and Ireland @
2021 -2021 Coagulation Business Unit Lead (Vice President) - USA @
2020 -2021 Head of Complement Marketing (Executive Director) - USA @
2018 -2020 AHUS Marketing Lead (Snr Director) - USA @
2016 -2018 Business Unit Leader (Snr Director) PNH and aHUS - UK and Ireland @
2014 -2016 Marketing Director PNH - UK and Ireland @
2013 -2014 Sales Manager @
2013 -2013 UK KAM Lead @
2010 -2011 Snr Brand Manager - COPD @
2008 -2010 Brand Manager - Pain @
2008 -2008 Marketing Associate - CV and Diabetes @
2007 -2007 Global Marketing Associate @
Philip Davey Education
University of Wales, Swansea
Bachelor of Arts (B.A.) (Modern European History)
1997-2000
Philip Davey Skills
Leadership
Leading transformational change
Brand Development Strategy
Cardiology
Key Account Management
Sales
Biotechnology
Cultural Change
Global Marketing
Strategy
Sales Management
Hospital Sales
Sales Effectiveness
Marketing
Pharmaceutics
Cross Functional Team Leadership
Influential Communicator
Market Analysis
Diabetes
Management
Product Launch
Engagement
Pharmaceutical Industry
Pharmaceutical Sales
Market Access
Marketing Strategy
Rheumatology
Technology Appraisal Submission
Philip Davey Summary
Philip Davey, based in Hoddesdon, GB, is currently a General Manager UK and Ireland and Mid Size Markets (MSM) North at Alnylam Pharmaceuticals. Philip Davey brings experience from previous roles at Alnylam Pharmaceuticals and Alexion Pharmaceuticals, Inc.. Philip Davey holds a 1997 - 2000 Bachelor of Arts (B.A.) in Modern European History @ University of Wales, Swansea. With a robust skill set that includes Leadership, Leading transformational change, Brand Development Strategy, Cardiology, Key Account Management and more. Philip Davey has 1 emails on RocketReach.
Looking for a different Philip Davey?
Find contact details for 700 million professionals.